CAI vs EIX · rev $216.8M vs P/E 7.3, rev $17.60B
Caris Life Sciences, Inc. Common Stock (CAI) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported CAI revenue for 2025-09-30 was $216.8M. Net income was $24.3M. Revenue was up 19.5% from 2025-06-30 to 2025-09-30. CAI currently screens at market cap $5.22B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
CAI currently screens at market cap $5.22B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the CAI and EIX stock pages for the full models.
Not investment advice.